Effect of Smoking and Time of Day on Eosinophils
NCT07625111 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-06-04
Summary
The study investigates the effect of acute smoking and time of day on blood eosinophils in chronic smokers. Chronic cigarette smokers without chronic respiratory diseases smoking at least 8 cigarettes per day and never-smoking controls are examined. Blood eosinophil counts and surface molecules are measured at 8 and 12 am in both groups. In smokers, two measurements are performed (at least 4 weeks apart): one measurement with no smoking between 8 and 12 am, and another measurement with smoking of 8 cigarettes between 8 and 12 am.
Conditions
- Healthy
Interventions
- OTHER
-
Smoking for 4 hours
Smoking of 8 cigarettes in 4 hours
Sponsors & Collaborators
-
Marek Lommatzsch
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-07
- Primary Completion
- 2026-06-30
- Completion
- 2026-12-06
Countries
- Germany
Study Locations
More Related Trials
-
Eosinophil Markers and Development of Disease in Allergic Rhinitis
NCT01192386 ·Status: COMPLETED
-
Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements
NCT00466596 ·Status: COMPLETED ·Phase: PHASE1
-
Eosinophil Subpopulations in Eosinophilic-associated Diseases
NCT06911775 ·Status: NOT_YET_RECRUITING
-
Roflumilast In-Vitro Basophil Release
NCT00613587 ·Status: COMPLETED
-
Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma
NCT00295737 ·Status: TERMINATED ·Phase: NA
-
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
NCT03644680 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
NCT04835168 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.
NCT01134757 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
NCT02565212 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
NCT03023397 ·Status: TERMINATED ·Phase: PHASE1
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
NCT00561717 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine
NCT02513290 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease
NCT00569361 ·Status: COMPLETED ·Phase: NA
-
Controlled Exposure to Diesel Exhaust in Subjects With Allergic Rhinitis
NCT01617330 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Preseasonal Omalizumab Treatment
NCT04489121 ·Status: COMPLETED ·Phase: NA
-
Effect of Specific Immunotherapy to Dust Mites in Children With Asthma
NCT00496561 ·Status: UNKNOWN ·Phase: PHASE4
-
Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
NCT04670627 ·Status: COMPLETED
-
Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen
NCT00426179 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
NCT01052610 ·Status: UNKNOWN ·Phase: PHASE4
-
Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects
NCT00605852 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)
NCT00574210 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge
NCT00562120 ·Status: COMPLETED ·Phase: PHASE2